Michael R. Rose

Active 1980–2024

74
Papers
18,003
Citations
67
h-index
74
i10-index

Citations

Citations per year for Michael R. Rose1977: 1 citations1981: 3 citations1982: 7 citations1983: 10 citations1984: 14 citations1985: 32 citations1986: 11 citations1987: 24 citations1988: 26 citations1989: 23 citations1990: 28 citations1991: 44 citations1992: 29 citations1993: 49 citations1994: 59 citations1995: 68 citations1996: 77 citations1997: 87 citations1998: 89 citations1999: 120 citations2000: 126 citations2001: 132 citations2002: 87 citations2003: 131 citations2004: 97 citations2005: 116 citations2006: 98 citations2007: 136 citations2008: 81 citations2009: 131 citations2010: 118 citations2011: 102 citations2012: 142 citations2013: 107 citations2014: 108 citations2015: 107 citations2016: 104 citations2017: 121 citations2018: 117 citations2019: 351 citations2020: 321 citations2021: 268 citations2022: 213 citations2023: 143 citations2024: 305 citations2025: 100 citations2026: 4 citations1978–1980: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,624 citing papers, 27.8% of this breakdownUnited Kingdom: 726 citing papers, 12.4% of this breakdownCanada: 331 citing papers, 5.7% of this breakdownFrance: 329 citing papers, 5.6% of this breakdownGermany: 294 citing papers, 5.1% of this breakdownAustralia: 253 citing papers, 4.3% of this breakdownNetherlands: 241 citing papers, 4.1% of this breakdownSwitzerland: 168 citing papers, 2.9% of this breakdownItaly: 159 citing papers, 2.7% of this breakdownChina: 156 citing papers, 2.7% of this breakdownSpain: 130 citing papers, 2.2% of this breakdownJapan: 110 citing papers, 1.9% of this breakdown
0%27.8%Other 22.6%

Fields

  • Biochemistry, Genetics and Molecular Biology42.9%
  • Medicine26.4%
  • Agricultural and Biological Sciences8.9%
  • Environmental Science6.9%
  • Social Sciences4.9%
  • Neuroscience2.9%
  • Other7.1%

Topics

  • Evolution and Genetic Dynamics7.7%
  • Genetics, Aging, and Longevity in Model Organisms5.2%
  • Inflammatory Myopathies and Dermatomyositis3.5%
  • Animal Behavior and Reproduction3.4%
  • Evolutionary Game Theory and Cooperation3.1%
  • Physiological and biochemical adaptations2.9%
  • Other74.2%

Coauthors

All papers

Open in search
  1. Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David R. Boulware, Blake Anderson, Riannon C Atwater, Nandini Avula, Kenny Beckman, Hrishikesh Belani, David R. Boulware, Carolyn T. Bramante, Jannis Brea, Courtney A. Broedlow, John B. Buse, Paula Campora, Anup P. Challa, Jill Charles, Grace M. Christensen, Theresa Christiansen, Ken Cohen, Bo Connelly, Srijani Datta, Nikita Deng, Alex T Dunn, Spencer M Erickson, Faith M Fairbairn, Sarah L. Fenno, D Fraser, Regina Fricton, Gwen Griffiths, Aubrey A Hagen, Katrina M Hartman, Audrey Hendrickson, Jared D. Huling, Nicholas E. Ingraham, Arthur Jeng, Darrell M Johnson, Amy B. Karger, Nichole R. Klatt, Erik A Kuehl, Derek LaBar, Samuel Lee, David Liebovitz, Sarah Lindberg, Darlette Luke, Rosario Machicado, Zeinab Mohamud, Thomas A. Murray, Rumbidzai Ngonyama, Jacinda M. Nicklas, David J. Odde, Elliott Parrens, Daniela Parra, Barkha P. Patel, Jennifer Proper, Matthew F Pullen, Michael A. Puskarich, Via Rao, Neha V Reddy, Naveen Reddy, Katelyn Rypka, Hanna G Saveraid, Paula Seloadji, Arman A. Shahriar, Nancy E. Sherwood, Jamie L Siegart, Lianne Siegel, Lucas Simmons, Isabella Sinelli, Palak Singh, Andrew Snyder, Maxwell T Stauffer, Jennifer L. Thompson and 8 more - The Lancet Infectious Diseases 2023 cited by 223

  2. How to select outcome measurement instruments for outcomes included in a “Core Outcome Set” – a practical guideline

    Authors: , , , , , , , - Trials 2016 cited by 1,145

  3. Long-Term Experimental Evolution in Escherichia coli. I. Adaptation and Divergence During 2,000 Generations

    Authors: , , , - The American Naturalist 1991 cited by 1,697

  4. 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands

    Authors: , , , , , , , , - Neuromuscular Disorders 2004 cited by 937

  5. 188th ENMC International Workshop: Inclusion Body Myositis, 2–4 December 2011, Naarden, The Netherlands

    Authors: - Neuromuscular Disorders 2013 cited by 387

  6. Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jennifer L. Thompson, Nancy E. Sherwood, Thomas A. Murray, Michael R. Rose, David R. Boulware, Jared D. Huling, COVID-OUT Study Team, Blake Anderson, Riannon C Atwater, Nandini Avula, Kenny Beckman, Hrishikesh Belani, David R. Boulware, Carolyn T. Bramante, Jannis Brea, Courtney A. Broedlow, John B. Buse, Paula Campora, Anup P. Challa, Jill Charles, Grace M. Christensen, Theresa Christiansen, Ken Cohen, Bo Connelly, Srijani Datta, Nikita Deng, Alex T Dunn, Spencer M Erickson, Faith M Fairbairn, Sarah L. Fenno, D Fraser, Regina Fricton, Gwen Griffiths, Aubrey A Hagen, Katrina M Hartman, Audrey Hendrickson, Jared D. Huling, Nicholas E. Ingraham, Arthur Jeng, Darrell M Johnson, Amy B. Karger, Nichole R Klatt, Erik A Kuehl, Derek LaBar, Samuel Lee, David Liebovitz, Sarah Lindberg, Darlette Luke, Rosario Machicado, Zeinab Mohamud, Thomas A. Murray, Rumbidzai Ngonyama, Jacinda M Nicklas, David J. Odde, Elliott Parrens, Daniela Parra, Barkha Patel, Jennifer Proper, Matthew F Pullen, Michael A. Puskarich, Via Rao, Neha V Reddy, Naveen Reddy, Katelyn Rypka, Hanna G Saveraid, Paula Seloadji, Arman A. Shahriar, Nancy E. Sherwood, Jamie L Siegart, Lianne Siegel and 14 more - Clinical Infectious Diseases 2024 cited by 46

  7. Evolution of senescence: late survival sacrificed for reproduction

    Authors: , - Philosophical Transactions of the Royal Society B Biological Sciences 1991 cited by 1,121

  8. Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a ‘core outcome set’

    Authors: , , , , , , , - Trials 2014 cited by 333

  9. Genome-wide analysis of a long-term evolution experiment with Drosophila

    Authors: , , , , , - Nature 2010 cited by 491

  10. Laboratory Evolution of Postponed Senescence in Drosophila melanogaster

    Authors: - Evolution 1984 cited by 682

  11. LABORATORY EVOLUTION OF POSTPONED SENESCENCE INDROSOPHILA MELANOGASTER

    Authors: - Evolution 1984 cited by 793

  12. GENETICS OF LIFE HISTORY IN DROSOPHILA MELANOGASTER. II. EXPLORATORY SELECTION EXPERIMENTS

    Authors: , - Genetics 1981 cited by 423

  13. Phenotypic plasticity and selection in Drosophila life‐history evolution. I. Nutrition and the cost of reproduction

    Authors: , , , - Journal of Evolutionary Biology 1993 cited by 384

  14. The validity of the International Physical Activity Questionnaire (IPAQ) for adults with progressive muscle diseases

    Authors: , , , - Disability and Rehabilitation 2021 cited by 42

  15. Physiological Mechanisms of Evolved Desiccation Resistance in Drosophila Melanogaster

    Authors: , , - Journal of Experimental Biology 1997 cited by 431

  16. Antagonistic pleiotropy, dominance, and genetic variation

    Authors: - Heredity 1982 cited by 406

  17. Hormones and the Physiological Architecture of Life History Evolution

    Authors: , - The Quarterly Review of Biology 1995 cited by 374

  18. GENETICS OF LIFE HISTORY IN DROSOPHILA MELANOGASTER. I. SIB ANALYSIS OF ADULT FEMALES

    Authors: , - Genetics 1981 cited by 369

  19. A test of evolutionary theories of senescence

    Authors: , - Nature 1980 cited by 352

  20. COMPLEX TRADE-OFFS AND THE EVOLUTION OF STARVATION RESISTANCE INDROSOPHILA MELANOGASTER

    Authors: , , - Evolution 1996 cited by 276

  21. Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Neurology 2012 cited by 111

  22. The Gompertz equation as a predictive tool in demography

    Authors: , , - Experimental Gerontology 1995 cited by 107

  23. What is Aging?

    Authors: , , , , , , , , - Frontiers in Genetics 2012 cited by 92

  24. Rasch analysis of clinical outcome measures in spinal muscular atrophy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Muscle & Nerve 2013 cited by 78